As part of its plans to reevaluate trial sector changes to generate new opportunities, Clario sold its eClinical technology to Miami-based CRO Sitero in August for an undisclosed price.

Clinical trial tech company Clario has sealed its second acquisition in a week, doubling down further on neuroscience by picking up imaging specialist NeuroRx. NeuroRx founder and CEO Douglas ...

The company recently inked a deal with fellow CRO ZIDDI, based in Belgium, that allows access to Clario’s randomization and trial supply management platform for remote, hybrid and traditional ...

Miami-based CRO Sitero has acquired eClinical technology from Clario in a move to provide a wider range of services. Clario’s tech will be integrated with Sitero’s Mentor platform and is ...

Clinical health tech company Clario has rolled out its latest offering—a cloud-based tool that allows sponsors and CROs to view medical images of their clinical trials. Dubbed Image Viewer ...

Earlier this month, Clario sold its eClinical technology to Miami-based CRO Sitero for an undisclosed price. In March, Clario debuted its cloud-based tool that allows sponsors and CROs to view ...

Health tech firm Clario is linking up with tech startup ArtiQ to leverage AI to fine-tune the collection of spirometry data in respiratory trials. Together, the two companies will be able to ...

Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "India Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing), By Model Type, By End-use (Biopharmaceutical ...

Tech firm Clario is boosting its electronic clinical outcome assessment (eCOA) offerings by acquiring the neuroscience-focused eCOA business of WCG. WCG's eCOA services provide specialized ...

In its second respiratory-focused deal of the month, Clario is partnering with Strados Labs to use its FDA-approved monitoring device for clinical trials. Under the agreement, Philadelphia-based ...

Clinical data company Clario and AI firm PathAI are teaming up to create an end-to-end imaging and pathology workflow for gastrointestinal clinical trials. The collaboration aims to provide ...

Drug-Trial Software Maker Clario Files Confidentially for IPO Clario targets valuation of more than $10 billion, sources say Private equity-backed company looking to list next year ...